Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion

Abstract

Summary: Simultaneous expression of Oct4, Klf4, Sox2, and cMyc induces pluripotency in somatic cells (iPSCs). Replacing Oct4 with the neuro-specific factor Brn4 leads to transdifferentiation of fibroblasts into induced neural stem cells (iNSCs). However, Brn4 was recently found to induce transient acquisition of pluripotency before establishing the neural fate. We employed genetic lineage tracing and found that induction of iNSCs with individual vectors leads to direct lineage conversion. In contrast, polycistronic expression produces a Brn4-Klf4 fusion protein that enables induction of pluripotency. Our study demonstrates that a combination of pluripotency and tissue-specific factors allows direct somatic cell transdifferentiation, bypassing the acquisition of a pluripotent state. This result has major implications for lineage conversion technologies, which hold potential for providing a safer alternative to iPSCs for clinical application both in vitro and in vivo. : The pluripotency- and neuro-specific factors Brn4, Klf4, Sox2, and cMyc (BKSM), when expressed individually, directly transdifferentiate fibroblasts into neutral stem cells (iNSCs). Velychko et al. show that polycistronic expression produces a fusion protein that induces pluripotency rather than direct transdifferentiation. Keywords: direct lineage conversion, transdifferentiation, reprogramming cell fate, induced neural stem cells, iPSC, pluripotency, polycistronic cassette, POU factor